“Off-label clofazimine dosing in children with rifampicin-resistant tuberculosis: Higher drug exposure and QTcF interval changes without severe prolongation”

https://pubmed.ncbi.nlm.nih.gov/38112526

This study found that off-label dosing of clofazimine in children with rifampicin-resistant tuberculosis results in higher drug exposure and is associated with increased QTcF interval, but severe prolongation is not observed.